Page 105 - ITPS-7-1

INNOSC Theranostics and
Pharmacological Sciences Plants immunoactivity: In silico study

28. Oliveros JC, 2007, VENNY. An Interactive Tool for e1002820.
Comparing Lists with Venn Diagrams. Available from: https://doi.org/10.1371/journal.pcbi.1002820
https://bioinfogp.cnb.csic.es/tools/venny/index.html [Last
accessed on 2021 Jul 10]. 40. Gupta M, Sharma R, Kumar A, 2018, Docking techniques in
pharmacology: How much promising? Comput Biol Chem,
29. Szklarczyk D, Franceschini A, Wyder S, et al., 2015, STRING 76: 210–217.
v10: Protein-protein interaction networks, integrated over
the tree of life. Nucleic Acids Res, 43: D447–D452. https://doi.org/10.1016/j.compbiolchem.2018.06.005
https://doi.org/10.1093/nar/gku1003 41. Cohen OC, Shadmi E, Keinan-Boker L, et al., 2019, The
association between patients’ perceived continuity of care
30. Shannon P, Markiel A, Ozier O, et al., 2003, Cytoscape: and beliefs about oral anticancer treatment. Supportive Care
A software environment for integrated models of Cancer, 27: 3545–3553.
biomolecular interaction networks. Genome Res,
13: 2498–2504. https://doi.org/10.1007/s00520-019-04668-6
https://doi.org/10.1101/gr.1239303 42. Medzhitov R, 2007, Recognition of microorganisms and
activation of the immune response. Nature, 449: 819–826.
31. Afolayan FID, Tarkaa CT, 2023, Network pharmacology-
based assessment of anti-inflammatory action of https://doi.org/10.1038/nature06246
phytocompounds derived from Nigella sativa and Moringa 43. Ramakrishnan V, Kumar S, 2018, PI3K/AKT/mTOR
oleifera. Drug Discov, 17: e13dd1016. pathway in multiple myeloma: From basic biology to clinical
32. Barabasi AL, Oltvai ZN, 2004, Network biology: promise. Leuk Lymphoma, 59: 2524–2534.
Understanding the cell’s functional organization. Nat Rev https://doi.org/10.1080/10428194.2017.1421760
Genet, 5: 101–113.
44. McDonald SJ, Sharkey JM, Sun M, et al., 2020, Beyond the
https://doi.org/10.1038/nrg1272 brain: Peripheral interactions after traumatic brain injury.
33. Reimand J, Kull M, Peterson H, et al., 2007, g: Profiler--a J Neurotrauma, 37: 770–781.
web-based toolset for functional profiling of gene lists from https://doi.org/10.1089/neu.2019.6885
large-scale experiments. Nucleic Acids Res, 35: W193–W200.
45. Kawai T, Akira S, 2007, Signaling to NF-κB by Toll-like
https://doi.org/10.1093/nar/gkm226 receptors. Trends Mol Med, 13: 460–469.
34. Swamydas M, Murphy EV, Ignatz-Hoover JJ, et al., 2022, https://doi.org/10.1016/j.molmed.2007.09.002
Deciphering mechanisms of immune escape to inform
immunotherapeutic strategies in multiple myeloma. 46. Napetschnig J, Wu H, 2013, Molecular basis of NF-κB
J Hematol Oncol, 15: 17. signaling. Annu Rev Biophys, 42: 443–468.
https://doi.org/10.1186/s13045-022-01234-2 https://doi.org/10.1146/annurev-biophys-083012-130338
35. Dallakyan S, Olson AJ, 2015, Small-molecule library 47. O’Shea JJ, Plenge R, 2012, JAK and STAT signaling
screening by docking with PyRx. Methods Mol Biol, molecules in immunoregulation and immune-mediated
1263: 243–250. disease. Immunity, 36: 542–550.
https://doi.org/10.1016/j.immuni.2012.03.014
https://doi.org/10.1007/978-1-4939-2269-7_19
36. BIOVIA, 2022, BIOVIA Workbook, Release 2020: BIOVIA 48. Hu YS, Han X, Liu XH, 2019, STAT3: A potential drug
Pipeline Pilot, Release 2022. San Diego: Dassault Systèmes. target for tumor and inflammation. Curr Top Med Chem,
19: 1305–1317.
37. Eberhardt J, Santos-Martins D, Tillack AF, et al., 2021,
AutoDock vina 1.2.0: New docking methods, expanded https://doi.org/10.2174/1568026619666190620145052
force field, and python bindings. J Chem Inform Model, 49. Ismail SI, Mahmoud IS, Msallam MM, 2010, Hotspot
61: 3891–3898. mutations of PIK3CA and AKT1 genes are absent in
https://doi.org/10.1021/acs.jcim.1c00203 multiple myeloma. Leuk Res, 34: 824–826.
https://doi.org/10.1016/j.leukres.2009.11.018
38. Sahu N, Mishra S, Kesheri M, et al., 2022, Identification of
Cyanobacteria-based natural inhibitors against SARS-CoV-2 50. Chang H, Qi XY, Claudio J, 2006, Analysis of PTEN deletions
druggable target ACE2 using molecular docking study, ADME and mutations in multiple myeloma. Leuk Res, 30: 262–265.
and toxicity analysis. Indian J Clin Biochem, 38: 361–373.
https://doi.org/10.1016/j.leukres.2005.07.008
https://doi.org/10.1007/s12291-022-01056-6
51. Peterson TR, Laplante M, Thoreen CC, 2009, DEPTOR is an
39. Cho DY, Kim YA, Przytycka TM, 2012, Chapter 5: Network mTOR inhibitor frequently overexpressed in multiple myeloma
biology approach to complex diseases. PLoS Comput Biol, 8: cells and required for their survival. Cell, 137: 873–886.

Volume 7 Issue 1 (2024) 16 https://doi.org/10.36922/itps.1076